壳聚糖／明胶磁性微球的反相悬浮乳液包埋法制备研究

在油包水（W／O）体系中,采用反相悬浮乳液包埋法,以戊二醛为交联剂,实现了壳聚糖和明胶（Gs／Gel）微球对Fe304磁性粒子的包裹．其制备的磁性微球粒径在3～8μm范围,分散性和磁响应性良好;磁性微球可较好地吸附BSA和亲和层析兔抗β-CNIgG,对后者的吸附率在48h稳定后可达到42．75％,为实验室制备高质量免疫磁性微球奠定了基础．     

壳聚糖为基质的左氧氟沙星缓释微球制备

以壳聚糖为基质,对左氧氟沙星缓释微球的制备方法进行了探索.确定了左氧氟沙星-壳聚糖缓释微球的制备工艺条件.通过考察微球的载药量及累积释放度,对上述制备方法工艺中的壳聚糖与盐酸左氧氟沙星的质量比、乳化剂Span用量、溶剂与壳聚糖溶液的体积比、交联剂戊二醛用量等因素进行了优化,制备出了具较好缓释效果的盐酸左氧氟沙星-壳聚糖缓释微球.该方法制备的左氧氟沙星-壳聚糖缓释微球载药量为43.88%,体外累积释放度的线形关系良好.     

微米级壳聚糖微球的制备

利用液体石蜡作有机分散介质、戊二醛作交联剂,通过反相悬浮交联法制备了微米级壳聚糖微球,并研究了反应条件对壳聚糖微球制备的影响。结果表明,壳聚糖溶液质量分数为4.5%、液体石蜡和壳聚糖溶液两相体积比1∶1.5、Span-80在油相中的质量浓度为9.0mg/mL、戊二醛和壳聚糖溶液体积比1∶20、搅拌转速大于800r/min时,SEM表明所制备产物是粒径10μm的壳聚糖微球。壳聚糖微球对活性物质具有一定的吸附能力。     

头孢替唑钠壳聚糖载药微球制备的研究

以虾壳为原料制备壳聚糖.通过反相悬浮交联法制备壳聚糖微球和头孢替唑钠载药微球.研究了醋酸浓度、壳聚糖浓度、乳化剂用量、油水比、交联密度、反应时间和搅拌速度等因素对微球平均粒径和粒径分散度的影响.     

磁性壳聚糖微球的制备及其性能

用共沉淀法制备纳米级Fe3O4磁流体,并对其用油酸进行表面改性。采用化学交联法,在分散有磁流体的壳聚糖溶液中,加入适量的戊二醛交联剂,制得内核为磁性Fe3O4,外层包有壳聚糖的纳米级的磁性壳聚糖复合微球。考察了壳聚糖质量浓度、NaOH滴加量及搅拌速度等因素对磁性壳聚糖微球粒径、粒径分布以及形貌等对复合过程的影响,确定了制备磁性壳聚糖微球的最佳条件,并用电镜、红外光谱图、粒径分析仪等方法对磁性壳聚糖微球的形态和组成特性进行分析。最后得出平均粒径为348.5 nm,表面富含羟基、氨基和醇羟基等官能团,磁性明显、分散性良好的磁性壳聚糖微球。     

涡流空化强化载药壳聚糖微球制备效果初探

为探讨涡流空化强化载药壳聚糖微球的制备效果,研究传统离子凝胶法制备壳聚糖载药微球的最佳工艺,了解空化强化制备的载药微球的体外释放规律,在单因素试验的基础上,通过四因素三水平的响应面分析法研究了壳聚糖质量浓度、甲基异噻唑啉酮(MIT)浓度、三聚磷酸钠(TPP)质量浓度、搅拌转速对壳聚糖抗菌微球包封率的影响.结果表明,响应面法优化的最佳工艺为:壳聚糖质量浓度3.5 g/L,MIT浓度0.50 mmol/L,TPP质量浓度2.5 g/L,搅拌转速1 500 r/min,搅拌时间20 min,载药微球包封率为37.64%;在此基础上,涡流空化20 min,涡流空化出口压力0.3MPa时,微球的包封率达50.33%,比传统法优化后制备微球的包封率高了12.69%;涡流空化制备的载药微球在体外释放60 h后,MIT的累积释放量达78.79%.与传统离子凝胶制备方法相比,涡流空化能有效提高壳聚糖微球载药的包封率.     

壳聚糖微球固定化脂肪酶催化性质研究

以壳聚糖微球为载体制备固定化脂肪酶制剂并研究其催化性质.首先,制备壳聚糖微球,用2%醋酸溶液溶解壳聚糖,以液体石蜡为分散剂制成壳聚糖微球;然后,通过戊二醛交联制备固定化脂肪酶制剂,并研究其催化性质.结果表明:壳聚糖微球在2%戊二醛浓度下常温下交联9 h,脂肪酶固载率可达60%.与游离脂肪酶相比,壳聚糖微球固定化脂肪酶的最适底物、最适p H值及最适温度分别转变为4-硝基苯基辛酸酯,p H 8.57及50℃.固定化脂肪酶重复实验6次后仍保留有47.7%的催化活性,置于60℃下4 h酶活保留73%,其金属离子K+和Mg2+最适浓度分别为0.15 mol/L,0.10 mol/L.     

聚甲基丙烯酸甲酯/壳聚糖复合微球的羧基化改性及其对Pb2+吸附行为

以壳聚糖为生物吸附剂,以甲基丙烯酸甲脂为聚合单体,采用悬浮聚合方法,经过表面羧基化改性,制备出了羧基化PMMA/壳聚糖复合微球。羧基化PMMA/壳聚糖复合微球的红外光谱在1630 cm~(-1)和666～800 cm~(-1)分别出现了特征峰,证实了表面—COOH与—NH_2的存在。热失重分析表明羧基化PMMA/壳聚糖复合微球在120℃以下具有很好的热稳定性。此外,吸附实验研究结果表明,羧基化PMMA/壳聚糖复合微球的吸附容量随着pH的下降而减小,在浓度小于100ppm的含铅溶液中铅离子去除率均能达到98%。以上结果表明制备的羧基化PMMA/壳聚糖复合微球对铅离子具有很好的吸附作用,是一种很有前景的铅离子吸附剂。     

孔板空化强化制备京尼平-壳聚糖载药纳米微球的工艺研究

以5-氟尿嘧啶(5-Fu)为模型药物,京尼平为交联剂,采用几何孔板空化强化乳化交联过程制备壳聚糖纳米微球,考察了孔板结构、入口压力、出口压力、交联温度、交联时间对空化数及其对微球平均粒径的影响,并与传统工艺进行了比较.结果表明:空化强度对微球的粒度大小存在显著影响;开孔率小,比周长大的几何孔板更有利于制备出超细粒度的纳米级微球.优化工艺参数为:单孔且孔径为3.0 mm的孔板,孔板入口压力0.28MPa,孔板出口压力0 MPa,交联温度60℃,交联时间40 min,制得的微球粒度最小为292.6 nm,孔板空化强化制备的微球粒度明显小于传统工艺制备的微球粒度.红外光谱(FT-IR)结果表明,在孔板空化作用下,模型药物5-Fu成功负载于壳聚糖微球中,且其结构未被破坏,说明孔板空化适用于强化乳化交联过程制备可负载药物的纳米级壳聚糖微球.     

酰化壳聚糖交联微球对铜离子吸附性能研究

以脱乙酰度95%的壳聚糖为原料,通过丁二酸酐酰化、氯化钙交联后对壳聚糖的改性,制备出吸附性能更好,稳定性更好的酰化壳聚糖交联微球。并研究了酰化壳聚糖交联微球对Cu~(2+)的吸附性能。实验结果表明:酰化壳聚糖交联微球对铜离子具有很好的吸附性能。吸附的最佳条件是:微球对铜离子吸附时间为60 min、pH值为6.0。在吸附过程中,ΔG~θ值在13.58～11.28 kJ·mol~(-1)之间,ΔH~θ=11.61 kJ·mol~(-1),ΔS=76.82 J·K~(-1)·mol~(-1),表明酰化壳聚糖微球吸附水中Cu~(2+)吸附是一个自发的吸热、熵过程。     

Evaluation of apatite-coated chitosan microspheres for bone regeneration

The apatite-coated chitosan microspheres were fabricated by incubating chitosan in five times simulated body fluid. The apatite deposited on the microspheres was similar to natural bone mineral, as demonstrated by scanning electron microscopy, X-ray diffraction spectra and Fourier transformed-infrared spectroscopy analyses. Rat bone marrow-derived mesenchymal stem cells （BMSCs） were seeded on apatite- coated microspheres to investigate the effect of this scaffold on cell proliferation and differentiation. BMSCs seeded on uncoated microspheres were served as a control. In vivo experiment was evaluated by transplanting the microspheres loaded with or without BMSCs in 5-mm cranial defects of Wistar rats. Bone regeneration was investigated via micro-CT and histological analysis. It was found that apatite-coated chitosan microspheres could significantly promote the proliferation and alkaline phosphatase activity of BMSCs compared with uncoated microspheres. Histological slices and Micro-CT images at 8 weeks revealed much better regeneration of bone in the apatite-coated microspheres loaded with BMSCs than the control. In addition, the defect filled with pure microspheres induced little new bone formation. Our findings suggest that the apatite-coated chitosan microspheres scaffold is a promising carrier of stem cells for cranial bone tissue engineering.     

京尼平交联壳聚糖微球的制备及理化性质

以壳聚糖为原料,京尼平为交联剂,采用乳化化学交联法制备壳聚糖载药微球,并利用单因素试验方法得出最佳制备工艺条件。采用扫描电镜（SEM）、显微镜、傅里叶红外光谱（FT—IR）及紫外光谱（UV）等现代仪器和对其形貌结构、反应机制等进行研究。结果表明：最佳工艺条件为温度30℃,10mL的6g／L的壳聚糖乙酸溶液（2％,WV）,京尼平溶液（70g／L）6mL,油水比为1：5。交联机制为shift反应机制。     

β-环糊精改性壳聚糖微球的制备及其性能研究

采用反相悬浮法,通过环氧氯丙烷交联制备β-环糊精改性交联壳聚糖微球(CDS),用FTIR和SEM进行表征,研究其对甲基橙(MO)的吸附和缓释性能。考察吸附时间、溶液p H值、MO浓度、温度等因素对CDS微球吸附的影响,并与交联壳聚糖(CTS)微球进行比较。结果表明,在p H 4.0、交联CTS微球1h可达吸附平衡,而CDS 2 h达到平衡;吸附数据均符合Freundlich等温方程和二级动力学方程。     

磁性壳聚糖微球的制备及其性能

用共沉淀法制备纳米级Fe3O4磁流体,并对其用油酸进行表面改性.采用化学交联法,在分散有磁流体的壳聚糖溶液中,加入适量的戊二醛交联剂,制得内核为磁性Fe304,外层包有壳聚糖的纳米级的磁性壳聚糖复合微球.考察了壳聚糖质量浓度、NaOH滴加量及搅拌速度等因素对磁性壳聚糖微球粒径、粒径分布以及形貌等对复合过程的影响,确定了...     

多胺化壳聚糖微球固定化AS1.398中性蛋白酶

从自制的单分散微米级壳聚糖微球出发,经C2氨基苯甲醛保护、C6羟基环氧化后接枝亲水性多胺,进一步制备多胺化壳聚糖载体,采用该载体对AS1.398中性蛋白酶进行固定化.结果表明：制备的固定化酶活力回收率达49%以上,是采用未改性壳聚糖微球固定化的2.7倍.固定化酶连续重复使用9批次后仍保留有原活力的一半.     

Chitosan andβ-cyclodextrin Microspheres as Pulmonary Sustained Delivery Systems

Chitosan and a-cyclodextrin were used to prepare microspheres with theophylline for pulmonary delivery by spray drying method.The characteristics,mucociliotoxicity,permeation rate and drug release were studied.The drug entrapments of microspheres Ⅰ,Ⅱ and Ⅲ were from 35.70%to 21.09% and 13.33%.while yields and encapsulation efficiencies were higher than 45%and about 90%respectively.with smooth or wrinkled surface surfaces.FT-IR demonstrated theophylline had formed hydrogen bonds with chitosan and a-cyclodextrin.The mierospheres could effectively reduce the ciliotoxicity and easy to penetrate the memberine.The in vitro release of the microspheres was related to the ratio of drug/polymer and microspheres Ⅱ had a prolong release,providing the release of 72.00%in 12 h.The results suggestes that chitosan/ a-cyclodextrin microspheres Ⅱ are a promising carrier as sustained release for pulmonary delivery.     

Preparation and characterization of chitosan microsphere loading bovine serum albumin

To optimize the preparation process of chitosan microspheres and study its loading capacity, chitosan microsphere was prepared by crosslinking with glutaraldehyde, and bovine serum albumin (BSA) was absorbed onto chitosan microsphere. Scanning electron microscope (SEM), Fourier transform infrared spectroscopy (FITR), TA instruments and zeta potentiometer analyzer were used to characterize the parameters with respect to size, thermal characters, morphology, and zeta potential of the microspheres. The loading capability and in vitro release tests were carried out. The results showed that chitosan microsphere with particle size less than 10 μm and positively charged (+25.97±0.56 mV) can be obtained under the aldehyde group to amino group ratio at 1:1. A loading capacity of BSA at 28.63±0.15 g/100 g with corresponding loading efficiency at 72.01±1.44% was obtained for chitosan microsphere. In vitro test revealed a burst release followed by sustained-release profile.     

磁性壳聚糖微球固定化脂肪酶的研究

以纳米级磁性壳聚糖微球为载体,戊二醛为交联剂固定化脂肪酶,对固定化脂肪酶条件进行优化,同时对固定化脂肪酶的理化性质、活性回收率、热稳定性和储存稳定性进行研究.结果表明,固定化脂肪酶的最佳时间为7 h,最佳pH为8,最佳温度为50 ℃,最佳酶加量为每100 mg磁性微球加酶10 mg.和自由酶相比,脂肪酶被磁性壳聚糖固定...